These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1264652)

  • 1. [The drug industry. A leading economic activity. 1. The companies The medication market].
    Veylon R
    Nouv Presse Med; 1976 Jan; 5(2):97-101. PubMed ID: 1264652
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic problems in drug distribution.
    Rucker TD
    Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974
    [No Abstract]   [Full Text] [Related]  

  • 3. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess profits in the drug industry and their effect on consumer expenditures.
    Doherty N
    Inquiry; 1973 Sep; 10(3):19-30. PubMed ID: 4269726
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmaceutical industry--to whom is it accountable?
    Summers WK; Driscoll J; Orient JM
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183883
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical expenditure compared across countries.
    van Mosseveld C
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs as an economic factor].
    Wülfrath H
    Offentl Gesundheitswes; 1970 Jul; 32(7):348-52. PubMed ID: 4247241
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE; Yerram CB; Saberwal G
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The drug industry. An economic activity. III. Economics of health. Future of the pharmaceutical industry].
    Veylon R
    Nouv Presse Med; 1976 Jan; 5(4):217-21. PubMed ID: 1264680
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmaceutical industry: a further study in corporate power.
    McCraine N; Murray MJ
    Int J Health Serv; 1978; 8(4):573-88. PubMed ID: 730410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug industry and research].
    Occelli R
    Rev Prat; 1972 Nov; 22(30):Suppl:3-7. PubMed ID: 4632003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug problems and the Common Market. Personal views].
    Andersen AH
    Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706
    [No Abstract]   [Full Text] [Related]  

  • 14. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMS updates HMM's pharmacy indexes.
    Doyle JJ
    Hosp Mater Manage; 1991 Jan; 16(1):19-22. PubMed ID: 10170632
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmaceutical industry during the Second World War: issues and evolution].
    Bonnemain B
    Rev Hist Pharm (Paris); 2002; 50(336):629-46. PubMed ID: 12712987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outsourcing lead optimization: constant change is here to stay.
    Clark DE
    Drug Discov Today; 2007 Jan; 12(1-2):62-70. PubMed ID: 17198974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the market ready for direct pharmaceutical contracting by employers?
    Giaquinta D
    Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.